Vorinostat Recruiting Phase 1 Trials for Alzheimer's Disease (AD) Basic Science

IndicationsStatusPurposePhase
RecruitingBasic Science1
clinicaltrials.gov IdentifierTitleDrugs
NCT03056495Clinical Trial to Determine Tolerable Dosis of Vorinostat in Patients With Mild Alzheimer Disease